ArticleJournal of health economics and outcomes research2025

Costs of Adverse Event Management Associated with First-Line Cetuximab or Panitumumab in Metastatic Colorectal Cancer Patients in Saudi Arabia.

Gihan Elsisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.